November 18, 2026
Health news, explained with evidence
LIVE

Blood Biomarkers Linked to Metabolic and Liver Stress in Patients with Diabetes and Hypothyroidism

❤️ Conditions & Care 2 min read 👁 4

A new study published in Nature Health Sciences investigates how the coexistence of type 2 diabetes and hypothyroidism alters circulating exosomal miRNAs, potentially offering new diagnostic pathways.

❤️Conditions & Care

Key points

  • Examined 143 participants across healthy, diabetes-only, and diabetes-with-hypothyroidism groups
  • Identified significant upregulation of exosomal miR-34 and miR-122 in patients with combined conditions
  • Observed progressive stepwise deterioration in biochemical markers of insulin resistance and liver health

Researchers examined 143 participants to understand how type 2 diabetes mellitus combined with clinical or subclinical hypothyroidism impacts metabolic and hepatic dysfunction. The study, conducted by a team from institutions including Shahid Chamran University of Ahvaz, isolated circulating exosomes from serum samples and tracked specific microRNAs, namely miR-34 and miR-122. Biochemical assessments revealed that parameters associated with insulin resistance and liver health progressively deteriorated across groups, with the most pronounced changes appearing in patients managing both type 2 diabetes and clinical hypothyroidism.

The findings suggest that these exosomal biomarkers are significantly upregulated in individuals with dual diagnoses, and notably, even subclinical hypothyroidism contributes to elevated levels beyond diabetes alone. While receiver operating characteristic analysis indicated high diagnostic accuracy in this cohort, the study remains observational and is based on a relatively small participant pool of 143 individuals. Therefore, these findings are preliminary and do not establish a direct clinical cure or immediate diagnostic routine.

What to know: Exosomal miR-34 and miR-122 levels were markedly elevated in patients dealing with both type 2 diabetes and thyroid issues, pointing toward potential future biomarkers for metabolic tracking. Always talk to a doctor or healthcare provider for personal medical decisions, diagnosis, and management of chronic conditions.

Source Nature Health Sciences — nature.com/articles/s41598-026-78086-0 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.